Voice solutions that listen
CallAssure

Thrombosis Clinics

Using IVR to reduce the cost of Patient Outreach and Improve Patient Care

Vocantas has been helping Thrombosis clinics across Ontario reduce the cost of patient outreach and improve patient compliance for years, with its interactive voice response (IVR) solution.

Now with patients anxious to move to Pradaxa, the Vocantas solution can solve many of the issues that accompany the move to Pradaxa from Warfarin/Coumadin for hospitals and clinics.

Is patient outreach costing you an arm and a leg?

Dr. Marc A. Roger, Head of the Thrombosis and Hemostasis Program, Division of Hematology at The Ottawa Hospital, reports that the Vocantas IVR solution has enabled the TOH to reduce their Thrombosis clinic staff by half! Many chronic disease clinics throughout Ontario have been able to support more patients without any increase in overhead directly as a result of our IVR solution.

We are the low cost Thrombosis Clinic administration experts!

The IVR saves clinics money by automating patient follow up phone calls. By interacting directly with your existing database, the IVR calls each patient with dosing instructions, appointment reminders and compliance reminders.

Call us today we are here to help you reduce costs, track metrics, and improve patient outreach.

Call Ken, Director of Healthcare, 613.271.8853 just say "Ken'

or send us an email - info@vocantas.com

WHAT IS PRADAXA?

PRADAXA is a prescription blood-thinning medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it should. This can cause blood clots to form, increasing your risk of a stroke. PRADAXA lowers the chance of blood clots forming in your body.

Recent Articles:

August 2011 - Pradaxa® (dabigatran etexilate) revolutionizes stroke prevention in atrial fibrillation

May 2011 - Time to revisit dabigatran dose in the US?

October 2010 - PRADAX™ (Dabigatran Etexilate) Gains Approval In Canada For Stroke Prevention In Atrial Fibrillation

 

1.877.271.8853 just say 'Sales'

or Email us at info@vocantas.com

 

 

chronic diseases

Simple yet Effective for Chronic Disease Management >> Learn more

 

infectious disease monitoring

Track the health of key populations automatically and safely >> Read more

reduce adverse events

CallAssure reduces likelihood of adverse events View Success Story

 

 

Clinically-proven

Vocantas is unique in claiming that its healthcare solution has been used successfully in independent (non-sponsored) clinical studies. Read more >